Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Studies demonstrate: Gastric ulcer healing Accelerated healing of various ulcer models including NSAID-induced, stress-induced, and cysteamine-induced ulcers (PMID: 21548867) Intestinal anastomosis repair Enhanced healing of surgical intestinal connections in rats (PMID: 17713731) Fistula healing Promoted closure of gastrointestinal fistulas in animal models (PMID: 32329684) Inflammatory bowel disease models Reduced inflammation and improved tissue integrity in colitis models Short bowel adaptation Improved adaptive response after massive intestinal resection, including increased villus height, crypt depth, and muscle thickness The gut-healing effects align with BPC-157's origin as a gastric juice peptide and represent the most biologically plausible therapeutic application
Improved healing of esophagogastric anastomosis: Studies have shown the application of BPC-157 and L-arginine improved the healing process in rats (8)
The FDA placed it in 503A Category 2 ("may present significant safety risks") in 2023, effectively barring compounding pharmacies from using it, then removed it from that category in April 2026 after nominators withdrew their submission, without adding it to the approved Category 1 compounding list
Frequency depends on your goals and individual needs
Results typically last several days to a week, and consistent sessions help sustain your energy and mental clarity long-term
US$ 20.87
US$ 25.92
US$ 21.09
